Page last updated: 2024-08-23

mifepristone and pasireotide

mifepristone has been researched along with pasireotide in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	8 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biller, BM; Tritos, NA	1
Schteingart, DE	1
Fleseriu, M; Petersenn, S	1
Barahona Constanzo, MJ; del Pozo Picó, C	1
Cohan, P	1
Hamrahian, AH; Hoffman, AR; Yuen, KC	1
Fleseriu, M	1
Ayala, A; Biller, BMK; Bonert, V; Broder, MS; Carmichael, JD; Cherepanov, D; Eagan, M; Geer, EB; Gordon, MB; Hannoush, Z; Katznelson, L; Lalazar, Y; Lee, J; Manuylova, E; Neary, MP; Pulaski-Liebert, KJ; Said, Q; Shafiq, I; Surampudi, V; Swerdloff, RS	1

Reviews

6 review(s) available for mifepristone and pasireotide

Article	Year
Advances in medical therapies for Cushing's syndrome. Discovery medicine, 2012, Volume: 13, Issue:69 Topics: Animals; Bexarotene; Cushing Syndrome; Etomidate; Humans; Ketoconazole; Lapatinib; Metyrapone; Mifepristone; Mitotane; Quinazolines; Somatostatin; Tetrahydronaphthalenes	2012
Medical management of Cushing's disease: what is the future? Pituitary, 2012, Volume: 15, Issue:3 Topics: Aminoglutethimide; Dopamine Agonists; Drug Therapy, Combination; Etomidate; Humans; Ligands; Mifepristone; Pituitary ACTH Hypersecretion; Pituitary Gland; PPAR gamma; Receptors, Glucocorticoid; Receptors, Somatostatin; Somatostatin	2012
New prospects for drug treatment in Cushing disease. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:10 Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Cabergoline; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Ergolines; Etomidate; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Metyrapone; Mice; Mifepristone; Mitotane; Multicenter Studies as Topic; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; PPAR gamma; Pyridines; Rats; Somatostatin; Therapies, Investigational; Tretinoin	2012
Pasireotide and mifepristone: new options in the medical management of Cushing's disease. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2014, Volume: 20, Issue:1 Topics: Adrenocorticotropic Hormone; Humans; Mifepristone; Pituitary ACTH Hypersecretion; Receptors, Glucocorticoid; Somatostatin	2014
AACE/ACE Disease State Clinical Review: Medical Management of Cushing Disease. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2014, Volume: 20, Issue:7 Topics: Adrenocorticotropic Hormone; Cabergoline; Drug Therapy, Combination; Ergolines; Humans; Ketoconazole; Mifepristone; Pituitary ACTH Hypersecretion; Somatostatin	2014
Medical treatment of Cushing disease: new targets, new hope. Endocrinology and metabolism clinics of North America, 2015, Volume: 44, Issue:1 Topics: Cytochrome P-450 Enzyme Inhibitors; Hormone Antagonists; Hormones; Humans; Imidazoles; Mifepristone; Pituitary ACTH Hypersecretion; Pyridines; Somatostatin	2015

Other Studies

2 other study(ies) available for mifepristone and pasireotide

Article	Year
Drugs in the medical treatment of Cushing's syndrome--an update on mifepristone and pasireotide. Expert opinion on emerging drugs, 2012, Volume: 17, Issue:3 Topics: Clinical Trials as Topic; Cushing Syndrome; Humans; Mifepristone; Receptors, Glucocorticoid; Receptors, Somatostatin; Somatostatin; Treatment Outcome	2012
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017, Volume: 23, Issue:8 Topics: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adrenalectomy; Adult; Aged; Antineoplastic Agents; Cabergoline; Comorbidity; Enzyme Inhibitors; Ergolines; Female; Follow-Up Studies; Hirsutism; Hormone Antagonists; Hormones; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Ketoconazole; Male; Metyrapone; Middle Aged; Mifepristone; Muscle Weakness; Muscular Atrophy; Neurosurgical Procedures; Obesity, Abdominal; Pituitary ACTH Hypersecretion; Pituitary Irradiation; Polycystic Ovary Syndrome; Retrospective Studies; Rosiglitazone; Somatostatin; Striae Distensae; Thiazolidinediones; Treatment Outcome; Tumor Burden; Young Adult	2017

Article

Year

Drugs in the medical treatment of Cushing's syndrome--an update on mifepristone and pasireotide.

Expert opinion on emerging drugs, 2012, Volume: 17, Issue:3

Topics: Clinical Trials as Topic; Cushing Syndrome; Humans; Mifepristone; Receptors, Glucocorticoid; Receptors, Somatostatin; Somatostatin; Treatment Outcome

2012

BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017, Volume: 23, Issue:8

Topics: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adrenalectomy; Adult; Aged; Antineoplastic Agents; Cabergoline; Comorbidity; Enzyme Inhibitors; Ergolines; Female; Follow-Up Studies; Hirsutism; Hormone Antagonists; Hormones; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Ketoconazole; Male; Metyrapone; Middle Aged; Mifepristone; Muscle Weakness; Muscular Atrophy; Neurosurgical Procedures; Obesity, Abdominal; Pituitary ACTH Hypersecretion; Pituitary Irradiation; Polycystic Ovary Syndrome; Retrospective Studies; Rosiglitazone; Somatostatin; Striae Distensae; Thiazolidinediones; Treatment Outcome; Tumor Burden; Young Adult

2017